95335 ⎘
Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
Sub-classes:VMAT2 INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#2Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2
#3Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2
#4BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
#5BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
#6Methods of manufacturing benzoquinoline compounds
#7Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2
#8SOLID STATE FORMS OF VALBENAZINE
#9Pharmaceutical compositions
#10AMORPHOUS AND CRYSTALLINE FORMS OF VALBENAZINE SALT
#11Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2
#12PROCESS FOR PREPARATION OF ((3R,11BR)-1,3,4,6,7,11B-HEXAHYDRO-9,10-DI(METHOXY-D3)-3-(2-METHYLPROPYL)-2H-BENZO[A]QUINOLIZIN-2-ONE
#13Dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis B virus infection
#14Process for preparation of Deutetrabenazine
#15Network-centric sensor coverage management
#16Cathode buffer layer material and organic photoelectric device including same
#17Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2
#18Solid state form of Valbenazine
#19METHODS OF MANUFACTURING BENZOQUINOLINE COMPOUNDS
#20METHODS OF MANUFACTURING BENZOQUINOLINE COMPOUNDS
#21Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#22BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
#23Esters of dihydrotetrabenazine
#24Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#25Pharmaceutical compositions
#26NOVEL THERAPEUTIC AGENTS FOR THE TREATMENT OF HBV INFECTION
#27Dihydroisoquinoline compound
#28Fused tricyclic compounds and uses thereof in medicine
#29Solid state forms of valbenazine
#30BENZOQUINOLONE INHIBITORS OF VMAT2
#31Network-centric sensor coverage management
#32Dihydroisoquinoline compound
#33Therapeutic compounds and methods of use thereof
#34ISOQUINOLINONE COMPOUNDS AND USE THEREOF IN PREPARATION OF ANTIVIRAL DRUGS
#35BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
#36Crystal forms of NBI-98854, preparation method and use thereof
#37Therapeutic agents for the treatment of HBV infection
#38Process for preparation of tetrabenazine and deutetrabenazine
#39METHODS OF MANUFACTURING BENZOQUINOLINE COMPOUNDS
#40Formulations And Pharmacokinetics Of Deuterated Benzoquinoline Inhibitors Of Vesicular Monoamine Transporter 2
#41Pharmaceutical compositions
#42Therapeutic agents for the treatment of HBV infection
#43Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection
#44STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ANTIBACTERIAL AGENT
#45BENZOQUINOLONE INHIBITORS OF VMAT2
#46Methods of manufacturing benzoquinoline compounds
#47BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
#48Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
#49Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
#50Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#51Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
#52BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
#53Process For The Preparation Of Pyrido[2,1-a] Isoquinoline Derivatives By Catalytic Asymmetric Hydrogenation Of An Enamine
#54Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection
#55METHODS OF MANUFACTURING BENZOQUINOLINE COMPOUNDS
#56Process For The Preparation Of Pyrido [2,1-A] Isoquinoline Derivatives Comprising Optical Resolution Of An Enamine
#57BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
#58BENZOQUINOLINE INHIBITORS OF VMAT 2
#59PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE
#60Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#61BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
#62Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#63Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2
#64BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
#65BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
#66PROCESS FOR THE PREPARATION OF PYRIDO [2,1-A] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE
#67BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2
#68Method of preparing tetrabenazine and dihydrotetrabenazine
#69Photoelectric conversion material, film containing the material, photoelectric conversion device, method for preparing photoelectric conversion device, method for using photoelectric conversion device, photosensor and imaging device
#70PROCESS FOR THE PREPARATION OF PYRIDO [2,1-A] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE
#71PROCESS FOR THE PREPARATION OF PYRIDO [2,1-a] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE
#72Process for the Preparation of Pyrido [2,1-a] Isoquinoline Derivatives by Catalytic Asymmetric Hydrogenation of an Enamine
#73BENZOQUINOLONE INHIBITORS OF VMAT2
#74Fluoroalkyl tetrabenazine carbinol compounds as imaging agents and probes
#75System of orienting femoral head for acetabular prosthesis alignment
#76PROCESS OF PREPARING A RADIOACTIVE COMPOUND CONTAINING A FLUORINE-18 ISOTOPE
#77SUBSTITUTED PYRIDO [1,2-a] ISOQUINOLINE DERIVATIVES
#78Benzoquinoline inhibitors of vesicular monoamine transporter 2
#79PHARMACEUTICAL COMPOUNDS
#80Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor
#81Intermediates for fluorinated tetrabenazine carbinol compounds imaging agents and probes
#82Intermediates for alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes
#83Intermediates for fluorinated dihydrotetrabenazine ether imaging agents and probes
#84Fluorinated dihydrotetrabenazine ether imaging agents and probes
#85Aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
#86Antipruritics
#87Intermediates useful for making tetrabenazine compounds
#88Method for making tetrabenazine compounds
#89Dihydrotetrabenazines And Pharmaceutical Compositions Containing Them
#90PROCESS FOR THE PREPARATION OF PYRIDO [ 2-1-A] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE
#91PROCESS FOR THE PREPARATION OF PYRIDO [2,1-a] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE
#92Glucocorticoid receptor modulators
#93Substituted pyrido [2,1-a] isoquinoline derivatives
#94Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor
#95Use of benzo[c]quinolizinium derivatives for the treatment of diseases that are linked to smooth muscle cell constriction
#96Antipruritics